Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

73,722 Press Releases · RSS · Email

Published on April 18, 2018 - 13:56 GMT

Rhino 69 Extreme 50000 by AMA Wholesale: Recall - Presence of Tadalafil

[Posted 04/18/2018] AUDIENCE: Consumer ISSUE: AMA Wholesale Inc. (Distributor/Re-seller), is voluntarily recalling Rhino 69 Extreme 50000 capsules to the consumer level. FDA analysis found the product to be tainted with undeclared tadalafil. Tadalafil is …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 18, 2018 - 13:32 GMT

Euphoric Capsules by Epic Products: Recall - Undeclared Sildenafil and Tadalafil

[Posted 04/18/2018] AUDIENCE: Consumer ISSUE: Overland Park, KS, Epic Products, LLC is voluntarily recalling all lots of Euphoric capsules, packaged in 1 count blister cards, 3 count bottles, and 12 count bottles to the consumer level. FDA analysis found …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 18, 2018 - 13:30 GMT

BriaCell Provides Highlights of Scientific and Clinical Findings at AACR

BERKELEY, Calif. and VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 18, 2018 - 13:27 GMT

VitalHub Reports 2017 Year End and Fourth Quarter Financial Results

TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) has released its audited financial results for the full year and fourth quarter ended December 31, 2017. When asked to comment on 2017’s Year-End Results, …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 13:02 GMT

Scythian Announces ABP S.A.’s First Purchase Order with Aphria Inc.

TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Argentina-based ABP S.A. (“ABP”), a pharmaceutical import and …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 18, 2018 - 13:00 GMT

Ogilvy CommonHealth Worldwide’s Goss and Sherman tapped to present at 2018 DTC National Conference

PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (www.ogilvychww.com), a WPP Health & Wellness company (NYSE:WPP) (www.wpp.com), today announced Catherine Goss, SVP, managing director, and Ashli Sherman, VP, client …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 13:00 GMT

Mydx Announces 2017 Fiscal Year Results

Gross Profit Margin Surged to 73% with Gross Profits Remaining Relatively Flat at ~$306K as MyDx Continues to Execute on its Long-Term Strategy SAN DIEGO, CA , April 18, 2018 (GLOBE NEWSWIRE) -- MyDx, Inc. (OTC: MYDX), a science and technology company and …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on April 18, 2018 - 13:00 GMT

TG Therapeutics, Inc. Announces Preclinical Data Presentation on the Company’s BET Inhibitor, TG-1601, at the 2018 American ...

NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced preclinical data for TG-1601, the Company’s novel BET inhibitor at the American Association for Cancer Research (AACR) annual meeting, taking place this week …

Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...
Published on April 18, 2018 - 13:01 GMT

OncoMed Presents Multiple Preclinical Abstracts Related to Immuno-Oncology Programs at the 2018 American Association for Cancer ...

REDWOOD CITY, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, presented preclinical data during the …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 12:45 GMT

CV Sciences, Inc. Announces Silver Level Sponsorship of the 15th Annual Nutrition and Health Conference in Boston, Massachusetts - ...

Company Continues its Expansion into the Healthcare Professional Market through One-on-One Education, Exclusive Product Offerings and Enhanced Practitioner Support. LAS VEGAS, April 18, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the " …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 12:45 GMT

Marrone Bio Innovations, Inc. Announces Pricing of Its Common Stock Offering

DAVIS, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (or "the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 12:35 GMT

Teladoc to Announce First Quarter 2018 Financial Results

PURCHASE, NY, April 18, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC), the world’s largest and most trusted provider of virtual care delivery services, announced today that it will release first quarter 2018 results on Tuesday, May 1, 2018, after the …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 12:30 GMT

Histogenics Corporation Announces the Appointment of Susan Washer to Its Board of Directors

WALTHAM, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies (RCTs) that may offer rapid-onset pain relief and restored function, today announced the …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 12:30 GMT

Origin Successfully Achieves Phase IIb GENESIS Trial Objectives Ahead of Schedule and Announces Early Termination of Study

PRINCETON, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Origin, Inc., a Phase IIb clinical-stage biotechnology company, today announced that the US Food and Drug Administration has approved its request to conclude patient recruitment in the “GENESIS” …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on April 18, 2018 - 12:30 GMT

Alder BioPharmaceuticals® to Present New Phase 3 Migraine Prevention Data for Eptinezumab at the 70th Annual American Academy of ...

BOTHELL, Wash., April 18, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it will present new Phase 3 …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 12:30 GMT

INSYS Therapeutics to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath-Actuated Device

PHOENIX, April 18, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced plans to advance clinical research of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 12:03 GMT

Red Cross steps up response in Niger as health conditions deteriorate

The rising number of people fleeing conflict and the arrival of thousands of migrants are overwhelming public health facilities in Niger, putting scores of families at risk – including tens of thousands of malnourished children. More than 400,000 people - …

Distribution channels: Culture, Society & Lifestyle, Environment ...
Published on April 18, 2018 - 12:00 GMT

Galectin Therapeutics to Present at 2nd Annual NASH Summit 2018

NORCROSS, Ga., April 18, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber, M.D., the Company’s CEO and CMO, has been selected as an …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 12:00 GMT

Retrotope Announces Peer-Reviewed Publication of Positive Phase 1b/2a Findings for RT001 in Friedreich’s Ataxia

Protocol for Pivotal Clinical Trial Has Been Submitted to the US FDA LOS ALTOS, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today peer-reviewed publication of positive Phase 1b/2a trial results for the company’s lead candidate, RT001, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 18, 2018 - 12:00 GMT

Trayt Unveils Application to Improve Diagnosis, Treatment and Quality of Life for Patients with Autism, ADHD and ...

REDWOOD CITY, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Trayt, the data analytics company with a platform for patients with neurodevelopmental and brain disorders, today announced the public availability of its mobile application. The application enables …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Previous 8 9 10 11 12 13 14 15 16 17 18 Next

Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

Browse by Topic